Mast cells and fibrosis in myeloproliferative neoplasms.
- Conditions
- itchingmyeloproliferative neoplasm10018865
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 62
Inclusion Criteria
- Age > 18 years
- Suspected MPN according to WHO criteria (i.e. essential thrombocytosis,
polycythemia vera, primary myelofibrosis, or post-ET or post-PV myelofibrosis)
- Previously proven MPN who did not yet receive pharmacotherapy.
- Patient is capable of giving informed consent
Exclusion Criteria
- Age < 18 years.
- Previous pharmacotherapy for MPN.
- Intended allogenic stem cell transplantation within 6 months after inclusion.
- Patients after hematopoietic stem cell transplantation
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method